Breaking News Instant updates and real-time market news.

SNY

Sanofi

$40.68

0.03 (0.07%)

11:15
03/13/18
03/13
11:15
03/13/18
11:15

Sanofi has a conference call hosted by JPMorgan

JPMorgan Analyst Vosser will host a conference call with CEO Olivier Brandicourt on March 13 at 11:30 am.

  • 13

    Mar

  • 25

    Mar

  • 02

    May

SNY Sanofi
$40.68

0.03 (0.07%)

03/12/18
PIPR
03/12/18
NO CHANGE
Target $182
PIPR
Overweight
Piper says Sanofi decision not to op-in on lumasiran positve for Alnylam
Piper Jaffray analyst Edward Tenthoff said he views Sanofi's (SNY) decision not to opt-in for global rights on lumasiran for the treatment of Primary Hyperoxaluria Type 1, or PH1, as a positive for Alnylam (ALNY), as he believes lumasiran could represent a fourth RNAi therapy with potential approval by 2020. Tenthoff, who said he is confident in FDA approval of patisiran by the August 11 PDUFA date and expects givosiran approval in 2019, keeps an Overweight rating and $182 target on Alnylam shares.
03/12/18
RILY
03/12/18
NO CHANGE
Target $200
RILY
Buy
Alnylam bear argument undercut by Regeneron data, says B. Riley FBR
B. Riley FBR analyst Madhu Kumar believes this weekend's Odyssey Outcomes data from Regeneron (REGN) and Sanofi (SNY) undercuts the bear argument on Alnylam Pharmaceuticals (ALNY) that PCSK9 drugs do not demonstrate clinically meaningful mortality benefit. Further, the analyst believes Sanofi and Regeneron's lower Praluent pricing in high-risk patients will likely expand uptake of PCSK9 drugs in the cholesterol market. Kumar keeps a Buy rating on Alnylam with a $200 price target.
02/26/18
LEER
02/26/18
NO CHANGE
LEER
Leerink remains positive on Regeneron/Sanofi Dupixent
Leerink analyst Geoffrey Porges says sentiment about the revenue potential of Regeneron (REGN)/Sanofi's (SNY) Dupixent has been declining over the past year, despite an impressive launch, and a steady flow of data for new indications and populations. The analyst remains positive about the product, forecasting 2020 revenue of $4B and growing to $6.5B by 2022 and $7.8B by 2025 from multiple indications.
02/19/18
JEFF
02/19/18
NO CHANGE
Target $145
JEFF
Buy
AnaptysBio price target raised to $145 from $101 at Jefferies
Jefferies analyst Biren Amin raised his price target for AnaptysBio (ANAB) to $145 after the company presented final data from its Phase IIa trial of ANB020 in 12 mod-to-severe adult atopic dermatitis patients. The shares closed Friday up $6.59, of 5.5%, to $126.45. Sustained efficacy on a single dose of '020 was seen up to day 78 at EASI-50 in 75% of patients, comparable to Phase II data from Sanofi (SNY) and Regeneron (REGN) competitor Dupixent, Amin tells investors in a research note. ANB020 beats if you account for single dose versus Q2 weeks of Dupi, the analyst contends. He keeps a Buy rating on AnaptysBio.

TODAY'S FREE FLY STORIES

12:47
12/14/18
12/14
12:47
12/14/18
12:47
Conference/Events
CFTC to hold a podcast on 2018 and 2019 »

Daniel Gorfine, the…

D

Dominion

$76.38

0.35 (0.46%)

12:46
12/14/18
12/14
12:46
12/14/18
12:46
Hot Stocks
Dominion board increases 2019 dividend 10% to $3.67 per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$38.09

0.6 (1.60%)

12:45
12/14/18
12/14
12:45
12/14/18
12:45
Options
Michael Kors call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
12/14/18
12/14
12:45
12/14/18
12:45
General news
U.S. equities remain upwardly challenged »

U.S. equities remain…

12:45
12/14/18
12/14
12:45
12/14/18
12:45
General news
Breaking General news story  »

Week of 12/14…

VLKAY

Volkswagen

$0.00

(0.00%)

, F

Ford

$8.60

0.095 (1.12%)

12:43
12/14/18
12/14
12:43
12/14/18
12:43
Periodicals
VW, Ford cooperation talks moving forward, Reuters says »

Volkswagen's (VLKAY)…

VLKAY

Volkswagen

$0.00

(0.00%)

F

Ford

$8.60

0.095 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

PNC

PNC Financial

$119.66

-0.25 (-0.21%)

12:43
12/14/18
12/14
12:43
12/14/18
12:43
Syndicate
Breaking Syndicate news story on PNC Financial »

PNC Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 12

    Apr

  • 17

    Jul

  • 16

    Oct

TRGP

Targa Resources

$42.36

-1.88 (-4.25%)

12:35
12/14/18
12/14
12:35
12/14/18
12:35
Options
Targa Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.15

-14.65 (-9.91%)

12:34
12/14/18
12/14
12:34
12/14/18
12:34
Recommendations
Johnson & Johnson analyst commentary  »

BMO Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.37

-14.43 (-9.76%)

12:31
12/14/18
12/14
12:31
12/14/18
12:31
Recommendations
Johnson & Johnson analyst commentary  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$2.39

-0.19 (-7.36%)

12:20
12/14/18
12/14
12:20
12/14/18
12:20
Options
Ratio put spread in Chesapeake as shares drop 7.3% and fall to 52-week lows »

Ratio put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/14/18
12/14
12:17
12/14/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/14/18
12/14
12:16
12/14/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.26

-14.54 (-9.84%)

, SBUX

Starbucks

$64.61

-2.29 (-3.42%)

12:15
12/14/18
12/14
12:15
12/14/18
12:15
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened lower…

JNJ

Johnson & Johnson

$133.26

-14.54 (-9.84%)

SBUX

Starbucks

$64.61

-2.29 (-3.42%)

ADBE

Adobe

$233.37

-14.34 (-5.79%)

COST

Costco

$207.71

-18.7 (-8.26%)

BEL

Belmond

$24.67

7 (39.62%)

LVMUY

LVMH

$0.00

(0.00%)

KANG

iKang Healthcare

$20.30

2.03 (11.11%)

IDRA

Idera Pharmaceuticals

$5.34

-1.26 (-19.09%)

CDE

Coeur Mining

$3.89

-0.165 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

PFE

Pfizer

$43.45

-1.105 (-2.48%)

12:14
12/14/18
12/14
12:14
12/14/18
12:14
Hot Stocks
Pfizer announces new $10B share repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:13
12/14/18
12/14
12:13
12/14/18
12:13
Hot Stocks
Pfizer raises quarterly dividend 6% to 36c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:12
12/14/18
12/14
12:12
12/14/18
12:12
Hot Stocks
Breaking Hot Stocks news story on Pfizer »

Pfizer boosts dividend to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ECA

Encana

$5.93

-0.295 (-4.74%)

12:10
12/14/18
12/14
12:10
12/14/18
12:10
Options
Call buyers in Encana as shares suffer additional losses »

Call buyers in Encana as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$2.76

0.02 (0.73%)

12:08
12/14/18
12/14
12:08
12/14/18
12:08
Hot Stocks
CVI Investments reports 9.9% passive stake in Tonix Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYH

Community Health

$3.94

-0.45 (-10.25%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Community Health falls -10.2% »

Community Health is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.65

-15.15 (-10.25%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Johnson & Johnson falls -10.3% »

Johnson & Johnson is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$101.00

-17 (-14.41%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -14.4% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIVI

Civitas Solutions

$14.68

2.05 (16.23%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Civitas Solutions rises 14.6% »

Civitas Solutions is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

SPY

SPDR S&P 500 ETF Trust

$262.10

-3.31 (-1.25%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Options
$10.5M sweep of SPDR 500 Trust upside calls »

$10.5M sweep of SPDR 500…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$73.25

9.63 (15.14%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 14.7% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.